About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Testing and Targeting KRAS-Mutant NSCLC
Testing and Targeting KRAS-Mutant NSCLC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Advancements in NSCLC: Multidisciplinary Case Panel Discussion
By
Yale Cancer Center
FEATURING
Steven Benaderet
,
Michael Cohenuram
,
Sarah Goldberg
,
Vincent Mase Jr
,
Daniel Rudolph
By
Yale Cancer Center
FEATURING
Steven Benaderet
,
Michael Cohenuram
,
Sarah Goldberg
,
Vincent Mase Jr
,
Daniel Rudolph
236 views
November 30, 2022
0 Comments
Login to view comments.
Click here to Login
Testing and Targeting KRAS-Mutant NSCLC
06:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "3-Year Results of the IFCT-1701 DICIPLE P…
Feat.
A. Toffart
33:14
Benjamin Herzberg
Direct KRAS Inhibition in NSCLC: Past, Present, and Future
09:17
Shirish Gadgeel
The Data on Novel KRAS G12C Inhibitors: Focus on Adagrasib
21:21
Johns Hopkins
KRASG12C Mutation in NSCLC: Current Data and Future Directions
Feat.
S. Rosner
14:37
OncoAlert
mNSCLC: Targeted Therapies Update
Feat.
S. Popat
10:29
NYU Langone
FDA Approval of Adagrasib in KRAS G12Cm NSCLC
Feat.
J. Sabari
08:22
ESMO 2022 Conference Coverage
ESMO 2022 on the Additional Practice-Informing Adverse Event Pattern…
Feat.
J. Zhang
24:33
Paul Hofman
Assessment of Co-Occurring Genomic Alterations in NSCLC
35:51
Yale Cancer Center
Advancements in NSCLC: Multidisciplinary Case Panel Discussion
Feat.
S. Benaderet,
M. Cohenuram,
S. Goldberg,
V. Mase Jr,
D. Rudolph
20:37
Jia Luo
Taking on Goliath: Targeting KRAS in NSCLC
18:14
Janakiraman Subramanian
Understanding KRAS G12C Positive Lung Cancer
29:00
GRACE
Therapeutic Options in Driver-Mutation Positive mNSCLC Refractory to…
Feat.
A. Desai